Literature DB >> 15817274

The effect of hypoxic-ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2.

James Aya-ay1, Joanne Mayer, Autumn K Eakin, Barbara G Muffly, Margaret Anello, John D Sandy, Paul E Gottschall.   

Abstract

Oligodendrocyte (OL) progenitor cells are particularly susceptible to perinatal hypoxia/ischemia (H-I) resulting in decreased myelination and attenuated development of white matter fiber tracts. Brevican is an aggregating chondroitin sulfate proteoglycan (CSPG) secreted by OLs and their progenitors prior to and during active developmental myelination whereas neuron-glia antigen 2 (NG2) is a transmembrane CSPG produced by early OL progenitors. Although both proteoglycans are associated with maturation of OLs, it is not known if they are altered by H-I brain injury in the neonate. We have therefore examined the time course of changes in brevican and NG2 abundance and proteolysis in the neonatal rat hippocampus after H-I. In a standard H-I model of unilateral carotid artery ligation and exposure to hypoxia, a cavitary infarct involving the ipsilateral parietal and temporal regions of cerebral cortex, hippocampus, and striatum of most rat pups was clearly evident 4 days after H-I. The abundance of total extractable brevican was markedly reduced in the ipsilateral hippocampus at 1 and 14 days after H-I (relative to the contralateral side). At these times, the total G1 proteolytic fragment of brevican was lower in the ipsilateral hippocampus and the level of a protease-generated brevican fragment was significantly diminished in the OL-rich hippocampal fimbria. Hippocampal NG2 levels were also lower at 1 and 4 days after H-I, but were not different from the contralateral side at 14 days. Since brevican, brevican G1 fragment, and NG2 loss occur around the time of progressive cell death and the appearance of the infarct, it may be that H-I rapidly induces a cellular response that actively depletes these proteoglycans from the hippocampal matrix. While the mechanism of this loss is unclear, it would appear to be an early event in the process that could be involved in apoptotic cell death and/or tissue injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817274     DOI: 10.1016/j.expneurol.2004.11.021

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Authors:  Le-Le Lu; Jing Sun; Jie-Juan Lai; Yan Jiang; Lian-Hua Bai; Lei-Da Zhang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 2.  Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury.

Authors:  Christopher C Giza; Bryan Kolb; Neil G Harris; Robert F Asarnow; Mayumi L Prins
Journal:  Dev Neurorehabil       Date:  2009       Impact factor: 2.308

3.  Intraventricular hemorrhage induces deposition of proteoglycans in premature rabbits, but their in vivo degradation with chondroitinase does not restore myelination, ventricle size and neurological recovery.

Authors:  Govindaiah Vinukonda; Muhammad T Zia; Bala B R Bhimavarapu; Furong Hu; Michelle Feinberg; Aqiba Bokhari; Zoltan Ungvari; Victor A Fried; Praveen Ballabh
Journal:  Exp Neurol       Date:  2013-03-06       Impact factor: 5.330

4.  Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited.

Authors:  N G Harris; S T Carmichael; D A Hovda; R L Sutton
Journal:  J Neurosci Res       Date:  2009-10       Impact factor: 4.164

5.  Disorganization of Oligodendrocyte Development in the Layer II/III of the Sensorimotor Cortex Causes Motor Coordination Dysfunction in a Model of White Matter Injury in Neonatal Rats.

Authors:  Yoshitomo Ueda; Sachiyo Misumi; Mina Suzuki; Shino Ogawa; Ruriko Nishigaki; Akimasa Ishida; Cha-Gyun Jung; Hideki Hida
Journal:  Neurochem Res       Date:  2017-07-31       Impact factor: 3.996

6.  Panel of synaptic protein ELISAs for evaluating neurological phenotype.

Authors:  Paul E Gottschall; Joanne M Ajmo; Autumn K Eakin; Matthew D Howell; Hina Mehta; Lauren A Bailey
Journal:  Exp Brain Res       Date:  2010-02-19       Impact factor: 1.972

7.  Selective decline of synaptic protein levels in the frontal cortex of female mice deficient in the extracellular metalloproteinase ADAMTS1.

Authors:  Matthew D Howell; Antoni X Torres-Collado; M Luisa Iruela-Arispe; Paul E Gottschall
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

Review 8.  Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury.

Authors:  Christopher C Leonardo; Keith R Pennypacker
Journal:  J Neuroinflammation       Date:  2009-04-15       Impact factor: 8.322

9.  Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain.

Authors:  Joanne M Ajmo; Autumn K Eakin; Michelle G Hamel; Paul E Gottschall
Journal:  BMC Neurosci       Date:  2008-01-25       Impact factor: 3.288

10.  Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat.

Authors:  Christopher C Leonardo; Autumn K Eakin; Joanne M Ajmo; Lisa A Collier; Keith R Pennypacker; Alex Y Strongin; Paul E Gottschall
Journal:  J Neuroinflammation       Date:  2008-08-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.